---
document_datetime: 2025-05-27 09:54:03
document_pages: 6
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/epruvy-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: epruvy-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 2.7360205
conversion_datetime: 2025-12-14 14:33:49.196615
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Epruvy

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                     | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| II/0002/G            | This was an application for a group of variations. B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.b.1.z - Replacement or addition of a | 10/04/2025                          |                                             | SmPC, Labelling and PL           |           |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The

CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

| manufacturing site for B.II.b.2.a - Change to arrangements and quality Replacement/addition control/testing takes place B.II.b.2.a - Change to arrangements and quality Replacement/addition control/testing takes place B.II.b.2.a - Change to arrangements and quality Replacement/addition control/testing takes place B.II.b.2.a - Change to arrangements and quality Replacement/addition control/testing takes place B.II.f.1.a.1 - Stability life of the finished product B.II.e.6.a - Change in packaging material not product formulation - product information B.II.d.1.c - Change in and/or limits of the finished new specification parameter its corresponding test B.II.d.1.c - Change in and/or limits of the finished new specification parameter its corresponding test   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

<!-- image -->

| and/or limits of the finished new specification parameter its corresponding test method B.II.d.1.c - Change in the and/or limits of the finished new specification parameter its corresponding test method B.II.d.1.c - Change in the and/or limits of the finished new specification parameter its corresponding test method B.II.d.1.c - Change in the and/or limits of the finished new specification parameter its corresponding test method B.II.b.3.c - Change in the the finished or intermediate a biological/immunological change requires an assessment B.II.b.1.c - Replacement manufacturing site for the manufacturing operation(s) release/control, and secondary biol/immunol medicinal forms manufactured by processes B.II.b.1.c - Replacement manufacturing site for the manufacturing operation(s) release/control, and secondary biol/immunol medicinal   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|                                        | - Change in immediate packaging of the product - Change in type/addition of a new - Sterile medicinal products and biological/immunological medicinal products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |            |                                  | processes B.II.e.1.b.2 finished container   |
|----------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|----------------------------------|---------------------------------------------|
| Variation type IA / EMA/VR/0000 246812 | This was an application for a group of variations. A.2 Change in the (invented) name of the medicinal product - A.2.a) for Centrally Authorised products - Accepted A. ADMINISTRATIVE CHANGES - A.4 Change in the name and/or address of: a manufacturer (including where relevant quality control testing sites); or an ASMF holder; or a supplier of the active substance, starting material, reagent or intermediate used in the manufacture of the active substance (where specified in the technical dossier) where no Ph. Eur. Certificate of Suitability is part of the approved dossier; or a manufacturer of a novel excipient (where specified in the technical dossier) - Accepted A.5 Change in the name and/or address of a manufacturer/importer of the finished product (including batch release or quality control testing sites) - A.5.b The activities for which the manufacturer/importer is responsible do not include batch release - Accepted ADMINISTRATIVE CHANGES - A.7 Deletion of | 06/02/2025 | SmPC, Annex II, Labelling and PL | A.                                          |

<div style=\"page-break-after: always\"></div>

|           | intermediate or finished product, packaging site, manufacturer responsible for batch release, site where batch control takes place, or supplier of a starting material, reagent or excipient (when mentioned in the dossier)* - Accepted B.I.a.4 Change to in-process tests or limits applied during the manufacture of the active substance - B.I.a.4.a Tightening of in-process limits - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |            |     |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| II/0001/G | This was an application for a group of variations. B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.I.a.4.a - Change to in-process tests or limits applied during the manufacture of the AS - Tightening of in-process limits B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits | 16/01/2025 | n/a |